Pei Li

773 total citations
24 papers, 633 citations indexed

About

Pei Li is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Pei Li has authored 24 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Pei Li's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (4 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Pei Li is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (4 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Pei Li collaborates with scholars based in China and United States. Pei Li's co-authors include Ziming Dong, Ping Chen, Tao Hu, Zhi‐Qiang Ling, Zheng Wu, Ningjing Lei, Liping Dai, Jianjun Lei, Qingyong Ma and Wanxing Duan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Pei Li

22 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pei Li China 14 392 356 101 74 63 24 633
Xiangdong Hua China 11 544 1.4× 397 1.1× 95 0.9× 65 0.9× 97 1.5× 20 764
Shengsheng Yang China 17 396 1.0× 312 0.9× 78 0.8× 104 1.4× 58 0.9× 34 734
Yue‐Zu Fan China 16 395 1.0× 365 1.0× 265 2.6× 74 1.0× 38 0.6× 34 746
Lisa K. Mullany United States 16 342 0.9× 135 0.4× 159 1.6× 69 0.9× 59 0.9× 18 633
Juhie Lee South Korea 13 327 0.8× 132 0.4× 104 1.0× 63 0.9× 87 1.4× 37 574
Sabrina De Carolis Italy 16 366 0.9× 234 0.7× 102 1.0× 37 0.5× 79 1.3× 19 618
Ruifen Dong China 15 419 1.1× 360 1.0× 111 1.1× 44 0.6× 28 0.4× 22 685
Lan Dai China 16 404 1.0× 233 0.7× 90 0.9× 26 0.4× 39 0.6× 39 701

Countries citing papers authored by Pei Li

Since Specialization
Citations

This map shows the geographic impact of Pei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Li more than expected).

Fields of papers citing papers by Pei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Li. The network helps show where Pei Li may publish in the future.

Co-authorship network of co-authors of Pei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Pei Li. A scholar is included among the top collaborators of Pei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei Li. Pei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Jing, et al.. (2024). Mitigation of nitrogen losses during pig manure management: Impact of manure cleaning technique. SHILAP Revista de lepidopterología. 8. 1–5.
3.
Li, Youli, et al.. (2024). Establishment of in vitro efficient regeneration system for leaves and hypocotyls of Toona sinensis, a multifunctional woody plants. Industrial Crops and Products. 224. 120328–120328. 2 indexed citations
4.
Zhang, Yanhong, et al.. (2024). Research on Breast Cancer Detection Methods Based on ODMV-MulDyHead-YOLO. IEEE Access. 12. 186819–186835. 1 indexed citations
5.
Jing, Xin, et al.. (2023). Pyroptosis and Inflammasome-Related Genes-NLRP3, NLRC4 and NLRP7 Polymorphisms Were Associated with Risk of Lung Cancer. Pharmacogenomics and Personalized Medicine. Volume 16. 795–804. 7 indexed citations
6.
Li, Pei, Yuzhen Niu, Shuyan Li, et al.. (2021). Identification of an AXL kinase inhibitor in triple‐negative breast cancer by structure‐based virtual screening and bioactivity test. Chemical Biology & Drug Design. 99(2). 222–232. 8 indexed citations
7.
Jing, Pengyu, et al.. (2020). miR‐24‐3p/KLF8 Signaling Axis Contributes to LUAD Metastasis by Regulating EMT. Journal of Immunology Research. 2020(1). 4036047–4036047. 18 indexed citations
8.
Lü, Xing, Hua Wen, Qing Li, et al.. (2019). Comparative analysis of growth performance and liver transcriptome response of juvenile Ancherythroculter nigrocauda fed diets with different protein levels. Comparative Biochemistry and Physiology Part D Genomics and Proteomics. 31. 100592–100592. 19 indexed citations
9.
Dang, Yunzhi, Pei Li, Jianping Li, et al.. (2018). The Efficacy and Late Toxicities of Computed Tomography-based Brachytherapy with Intracavitary and Interstitial Technique in Advanced Cervical Cancer. Journal of Cancer. 9(9). 1635–1641. 23 indexed citations
10.
Li, Pei, Yibo Gan, Yuan Xu, et al.. (2017). The inflammatory cytokine TNF-α promotes the premature senescence of rat nucleus pulposus cells via the PI3K/Akt signaling pathway. Scientific Reports. 7(1). 42938–42938. 70 indexed citations
11.
Dang, Yunzhi, Ying Zhang, Jianping Li, et al.. (2017). High VEGFR1/2 expression levels are predictors of poor survival in patients with cervical cancer. Medicine. 96(1). e5772–e5772. 24 indexed citations
12.
13.
Jiang, Liehao, Minghua Ge, Jun Cao, et al.. (2015). miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma. Laboratory Investigation. 95(12). 1398–1408. 47 indexed citations
14.
Hu, Tao, Pei Li, Zhongguang Luo, et al.. (2015). Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo. Oncology Reports. 35(1). 43–49. 52 indexed citations
15.
Xu, Qinhong, Pei Li, Xin Chen, et al.. (2015). miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases. Oncotarget. 6(16). 14153–14164. 71 indexed citations
16.
Chen, Ping, Tao Hu, Xiaoyu Chen, et al.. (2015). Abstract 2808: Luteolin inhibits cell proliferation and induces cell apoptosis via down-regulation of mitochondrial membrane potential in esophageal carcinoma cells EC1 and KYSE450. Cancer Research. 75(15_Supplement). 2808–2808. 91 indexed citations
17.
He, Na, Hong Zheng, Pei Li, et al.. (2014). miR-485-5p Binding Site SNP rs8752 in HPGD Gene Is Associated with Breast Cancer Risk. PLoS ONE. 9(7). e102093–e102093. 28 indexed citations
18.
Li, Pei, Qinhong Xu, Dong Zhang, et al.. (2014). Upregulated miR‐106a plays an oncogenic role in pancreatic cancer. FEBS Letters. 588(5). 705–712. 61 indexed citations
19.
Yuan, Na, Min Meng, Caigang Liu, et al.. (2013). Clinical characteristics and prognostic analysis of triple-negative breast cancer patients. Molecular and Clinical Oncology. 2(2). 245–251. 39 indexed citations
20.
Li, Pei, Weimin Mao, Zhiguo Zheng, Ziming Dong, & Zhi‐Qiang Ling. (2013). Down-Regulation of PTEN Expression Modulated by Dysregulated miR-21 Contributes to the Progression of Esophageal Cancer. Digestive Diseases and Sciences. 58(12). 3483–3493. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026